Max Ventilator Collaborates With US Firm to Match International Standards
The partnership will enable Max Ventilator to produce ventilators of international specs and enter in highly regulated market such as the US and the EU
On 28th August 2021, Indian ventilator maker, Max Ventilator entered into a technology collaboration with US-based firm, Amptron Medical, a respiratory technology player.
The partnership will enable Max Ventilator to produce ventilators of international specs and enter in highly regulated market such as the US and the EU.
“This strategic partnership move signals our intent to develop world-class lifesaving breathing machines and other medical devices according to international standards and certifications,” the company said in a statement.
Ashok Patel, the founder of Max Ventilator said, “Until now, Indian (breathing devices) products were limited to having Indian certifications. This also curtailed access to international markets for the products. However, with this joint venture with Amptron, Max intends to go truly global in its manufacturing outlook and approach to expand our presence in developed markets. We are confident that this collaboration will add strength to India’s quest for becoming a world-class manufacturer of ventilators and other medical devices.”
Max Ventilator will soon start producing products based on international technical and quality standards, leveraing Amptron’s R&D infrastructure and the team is based in the US. It will enable Max Ventilator to make products matching US/international approvals.
Nirav Patel, CEO, Amptron Medical, said, “With Max’s decades of medical technology-based product development experience and extensive on-the-ground market experience, this collaboration will give Amptron Medical the market access and reach it desires.”
The terms and conditions for licensing, manufacturing, and global marketing, sales, and distribution are being worked out between the companies. However, under the terms of agreement, Max would retain the right to marketing, sales, and distribution for the Indian market.
Recently, Max Ventilator and Amptron Medical developed a High-Flow Oxygen Therapy (HFOT) device with collaboration. The device provides nearly 100 per cent survival chances, and also entails less operating costs than a conventional ventilator and it emerged as a promising option for Covid patients.